Does IMATINIB Cause Recurrent cancer? 237 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 237 reports of Recurrent cancer have been filed in association with IMATINIB (Imatinib). This represents 0.6% of all adverse event reports for IMATINIB.
237
Reports of Recurrent cancer with IMATINIB
0.6%
of all IMATINIB reports
51
Deaths
26
Hospitalizations
How Dangerous Is Recurrent cancer From IMATINIB?
Of the 237 reports, 51 (21.5%) resulted in death, 26 (11.0%) required hospitalization, and 2 (0.8%) were considered life-threatening.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 237 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
OLAPARIB (77)
Which IMATINIB Alternatives Have Lower Recurrent cancer Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL